Irida Kastrati
0000-0002-8086-1411
Publication & Citation Trends
Publications
0 total
SELENOF and its translational inhibitor EIF4A3 are differentially expressed in colon cancer.
Cited by 0
Semantic Scholar
Abstract 1735: Expanding the therapeutic potential of TXNRD inhibitors for triple-negative breast cancer
Cited by 0
Semantic Scholar
Contributions of selenoproteins to breast cancer etiology and racial disparity
Cited by 0
Semantic Scholar
Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy
Cited by 1
Semantic Scholar
Abstract 4901: Investigating whether TXNRD2 is a therapeutic target against triple negative breast cancers using African American-derived models
Cited by 0
Semantic Scholar
Abstract 1498: SELENOF maintains proteostasis through UPR-IRE1α axis in breast cancer
Cited by 0
Semantic Scholar
Research Topics
Estrogen and related hormone effects
(45)
Cytokine Signaling Pathways and Interactions
(24)
NF-κB Signaling Pathways
(17)
Inflammatory mediators and NSAID effects
(10)
Redox biology and oxidative stress
(8)
Affiliations
University of Illinois Urbana-Champaign
Loyola University Chicago
University of Illinois Chicago
University of Chicago
May Institute